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Release of ATP in the Ventral Medulla during Hypoxia in
Rats: Role in Hypoxic Ventilatory Response
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P2X2 receptor subunits of the ATP-gated ion channels are expressed by physiologically identified respiratory neurons in the ventral
respiratory column, implicating ATP in the control of respiratory activity. We now show that, during hypoxia, release of ATP in the
ventrolateralmedulla (VLM)plays an important role in the hypoxic ventilatory response in rats. BymeasuringATP release in real time at
the ventral surfaceof themedullawithnovel amperometric biosensors,we found thathypoxia (10%O2; 5min) inducedamarked increase
in the concentration of ATP (3M). This ATP release occurred after the initiation of enhanced respiratory activity but coincided with
the later hypoxia-induced slowing of the respiratory rhythm. ATP was also released at the ventral surface of themedulla during hypoxia
in peripherally chemodenervated animals (vagi, aortic, and carotid sinus nerve sectioned). By using horizontal slices of the rat medulla,
we found that, during hypoxia, ATP is produced throughout the VLM in the locations corresponding to the ventral respiratory column.
Blockade ofATP receptors in theVLM(microinjection of P2 receptor antagonist pyridoxal-5-phosphate-6-azophenyl-2,4-disulphonic
acid; 100 M) augmented the hypoxia-induced secondary slowing of the respiratory rhythm. Our findings suggest that ATP released
within the ventral respiratory column is involved inmaintenance of the respiratory activity in conditionswhen hypoxia-induced slowing
of respiration occurs. These data illustrate a new functional role for ATP-mediated purinergic signaling in the medullary mechanisms
controlling respiratory activity.
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Introduction
The CNS of animals with high metabolic rates (mammals and
birds) is extremely sensitive to a decrease in PO2 in the arterial
blood (i.e., hypoxia). Oxygen sensors of the carotid bodies, lo-
cated strategically at the bifurcation of the common carotid ar-
tery, have evolved to monitor PO2 in the blood entering the brain
and to initiate adaptive changes in respiratory activity when hyp-
oxia occurs (Gonzalez et al., 1994; Daly, 1997; Prabhakar, 2000).
The hypoxic ventilatory response in adults consists of an initial
increase in respiration, followed by a secondary slowing of the
respiratory rhythm, known as the hypoxic ventilatory depression
(Richter et al., 1991; Bissonnette, 2000).We showed recently that,
within the carotid body, ATP released by the O2-sensitive glomus
cells and acting at P2X2 receptors located on the afferent termi-
nals of the carotid sinus nerve forms an essential link in periph-
eral chemosensory transduction, leading to the enhancement of
ventilation during hypoxia (Rong et al., 2003).
The mechanisms responsible for the hypoxia-induced sec-
ondary slowing of the respiratory rhythmare lesswell understood
(for review, see Bissonnette, 2000). Adenosine has been impli-
cated as a potential mediator (Runold et al., 1989; Thomas and
Marshall, 1994; Schmidt et al., 1995; Chau and Koos, 1999; Jo-
hansson et al., 2001). However, we recently demonstrated that
adenosine release in the medullary regions involved in respira-
tory control, nucleus tractus solitarii and rostral ventrolateral
medulla (VLM), occurs too late to be responsible for the initia-
tion of hypoxia-induced depression of the respiratory activity
(Gourine et al., 2002). Interestingly, the ecto-5-nucleotidase in-
hibitor ,-methylene ADP greatly reduced the release of aden-
osine during hypoxia at the dorsal surface of the medulla, sug-
gesting that it is produced in the extracellular space by the
previous release and breakdown of ATP (Gourine et al., 2002).
Furthermore, we recently found that P2X2-deficient mice exhib-
ited amuchmore profound hypoxia-induced ventilatory depres-
sion compared with their wild-type counterparts (Rong et al.,
2003), suggesting that the action of ATP on P2X2 receptors in
either the brain or the periphery may oppose ventilatory
depression.
Ionotropic P2X receptors of the ATP-gated ion channel
(North, 2002) are present in areas of the VLM corresponding to
the ventral respiratory column (Kanjhan et al., 1999; Yao et al.,
2000, 2003; Thomas et al., 2001), which is responsible for gener-
ation and patterning of the respiratory rhythm.More specifically,
we demonstrated that a significant proportion of the VLM respi-
ratory neurons express the P2X2 receptor subunit and increase
their discharge in response to ATP (Gourine et al., 2003). Our
previous studies also demonstrated that ATP contributes to the
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excitation of VLM inspiratory neurons during hypercapnia (for
review, see Spyer and Thomas, 2000). We proposed that ATP-
mediated purinergic signaling at the level of the ventral respira-
tory column may also play an important role in the respiratory
response to hypoxia and have therefore investigated this possible
role. Here, we report that ATP is released in the VLM in response
to hypoxia. This release of ATP at locations corresponding to the
ventral respiratory column helps to maintain respiratory activity
at the times when hypoxia-induced slowing of the respiratory
rhythm occurs.
Materials andMethods
Surgical procedures
Experiments were performed on 31 male Sprague Dawley rats (300–340
g) and were performed in accordance with the United KingdomAnimals
(Scientific Procedures) Act of 1986. The rats were anesthetized with pen-
tobarbitone sodium (Sagatal; 60 mg/kg, i.p.; Rhoˆne Me´rieux, Harlow,
UK). Anesthesia was maintained with supplemental doses of pentobar-
bitone sodium injected intravenously as required (10 mg  kg1  h1).
Adequate anesthesia was ensured by maintaining stable levels of arterial
blood pressure (ABP), heart, and central respiratory rates andmonitored
by the absence of a withdrawal response to a paw pinch. The femoral
artery and vein were cannulated for measurement of ABP and adminis-
tration of anesthetic, respectively. The trachea was cannulated, and the
animal was ventilated with a mixture of 50% O2 and 50% N2 (unless
otherwise required by the protocol) using a positive pressure ventilator
(Harvard rodent ventilator; model 683; Harvard Apparatus, Holliston,
MA) with a tidal volume of2 ml and a ventilator frequency similar to
the normal respiratory frequency (60 strokes/min). The animal was
then paralyzed with a neuromuscular blocker (gallamine triethiodide;
Flaxedil; 10 mg/kg, i.v.; maintained with supplemental doses of 1–2
mg  kg1  h1, i.v.) and was placed in a stereotaxic frame. Either the
ventral or dorsal surface of the brainstem was exposed. To expose the
dorsal medullary surface, an occipital craniotomy was performed, and
the cerebellum was partially removed. The exposed area of the brain was
protected by covering with modified Bulmer’s buffer, which consisted of
the following (in mM): 100 NaCl, 1 MgSO4, 2 KPi buffer, and 5 glycerol,
pH 7.4.
In five rats, peripheral chemodenervation was performed; the vagi and
the aortic nerves were sectioned bilaterally, and the carotid sinus nerves
were transected bilaterally at the junction with the glossopharyngeal
trunk.
Activity of the phrenic nerve was recorded as an indicator of central
respiratory drive. The signal was amplified (20,000), filtered (500–
1500 Hz), and rectified and smoothed (  50 ms). Partial pressures of
O2 and CO2, as well as pH of the arterial blood, were measured every 1–2
h. End-tidal levels of CO2 were monitored on-line using a fast-response
CO2 analyzer (CapStar-100; CWE, Ardmore, PA) and kept at designated
levels (either above or below the apneic threshold) by altering tidal vol-
ume and respiratory frequency. The body temperature was maintained
with a servo-controlled heating pad at 37.0 0.2°C.
Slice preparation for in vitro experiments
Young adult rats (5 weeks of age; 100–120 g; n  45) were killed by
cervical dislocation, and the brainstem was quickly removed from the
skull and placed in artificial CSF (aCSF) chilled to5°C: 124 mM NaCl,
3 mM KCl, 2 mM CaCl2, 26 mM NaHCO3, 1.25 mM NaH2PO4, 1 mM
MgSO4, and 10 mM D-glucose saturated with 95% O2 and 5% CO2, pH
7.4, with an additional 11 mM Mg2. The medulla oblongata was iso-
lated, and the arachnoidmatterwas removed, but the piawas left in place.
The isolated medulla was placed on a block, ventral side up, and hori-
zontal slices of 400mthickness were cut using a vibratome (see Fig. 4a).
Once cut, the slices were stored in a chamber containing normal aCSF
saturated with 95% O2 and 5% CO2, pH 7.4, at room temperature. Re-
cordings were made from the slices placed on an elevated grid in a flow
chamber at 35°C to permit access of O2/CO2-saturated aCSF from both
sides of the slice. Glycerol (2 mM) essential for ATP biosensor operation
(see below) was added to the aCSF. The rate of perfusion was 6 ml/min.
ATP biosensors
The principal design and operation of the enzyme-based biosensors used
in this study have been described in detail previously (Llaudet et al., 2003,
2004). The ATP sensors (Sarissa Biomedical, Coventry, UK) comprised two
enzymes, glycerol kinase and glycerol-3-phosphate oxidase entrapped
within amatrix around a fine platinum (Pt)wire of 100mindiameter and
1mm in length (Fig. 1). After fabrication, the sensors were bent so that they
could be placed parallel to and in contact with the exposed surface of the
medulla (Fig. 1b).
Electrochemical sensors can respond not only to the analyte of interest
but also to any electroactive species in the millieu. To ensure that the
sensors were responding specifically to ATP, we used a dual recording
configuration of an ATP sensor placed on one side of the medulla, along
with a null sensor lacking enzymes, which was placed in an equivalent
position on the other side of the medulla (Fig. 1b). The null sensors thus
served as a control to determine whether any “nonspecific” electroactive
Figure 1. Principle and performance of ATP biosensors and their placement on the ventral
surface of the medulla oblongata. a, Scheme of the sensor assembly. An expanded portion of
one side of the sensor is shown to indicate the enzymatic biolayer. Note that this biolayer
completely surrounds the Ptwire.b, Schematic showing of the sensor placement on the ventral
surface of themedulla oblongata. The sensorswere bent so that they could be placed parallel to
and in contact with the exposed surface of the medulla. A dual recording configuration of the
ATP sensor placed on one side of the medulla along with a null sensor that was placed in an
equivalent position on the other side of themedullawas used. c, The enzymatic cascade usedby
the ATP biosensors. The presence of the target analyte ATP results in the production of H2O2 ,
which is detected electrochemically. d, Calibration curve of the ATP biosensor, demonstrating
linearity of ATP detection in concentrations from 1 to 50M. Inset, Sample responses for the
ATP biosensor. e, An expanded portion of the calibration trace demonstrating the fast response
characteristics of theATPbiosensor,which reaches full responsewithin 10–13 s. Changeover of
the solution in the calibration chamber was not a step change. It would take a few seconds for
ATP to reach the desired concentration. Therefore, the trace shows a speed of response that is a
combination of the time taken for the change in ATP concentration in the chamber to occur and
the response of the sensor. Note that the sensor responds immediately when ATP solution is
starting to enter the chamber. f, Calibration trace showing that theATPbiosensorsare insensitive
to adenosine, UTP, or ADP. py, Pyramidal tract; XII, hypoglossal nerve roots.
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interferents were released and could confound the measurements. This
dual recording configuration was used for all of the experiments.
The ATP sensors are virtually insensitive to ADP, UTP, or adenosine
(Fig. 1f ). They require the presence of glycerol to be active; however, their
response is insensitive to variations in glycerol concentration over the
range of 0.5–5 mM. The magnitude of the response to ATP is also insen-
sitive to changes in pH.
Sensors were calibrated in vitro immediately before and after the re-
cordings (some 3–4 h later) to test whether they retained sensitivity. For
calibration, sensors were placed in a simple flow chamber that was con-
tinually perfused with control saline. The flow was switched to a saline
containing 10 M ATP to determine the sensitivity of the sensor. During
recordings in vivo, the sensors lost, on average, 70% of their initial
sensitivity. Virtually no decrease in the responsiveness of the sensors to
ATP occurred after their use in in vitro experiments. To convert changes
in sensor current to changes in ATP concentrations, the mean of the
initial and final calibrations was used.
Experimental protocols
Measurements of the hypoxia-induced changes in ATP concentration on the
ventral surface of the medulla. The sensors were connected to a MicroC
potentiostat (World Precision Instruments, Sarasota, FL) and held on a
stereotaxic micromanipulator. The sensors were aligned with the pyra-
midal tracts andmajor blood vessels running on the ventral surface of the
medulla and then were placed on the ventral surface 1.5–2.0 mm lateral
from themidline (Fig. 1b). The sensitive part of the sensor was1mm in
length and was placed in direct contact with a significant portion of the
chemosensitive area on the ventrolateral medullary surface. The record-
ing sites were located400–700 m ventrally from the rostral divisions
of the medullary ventral respiratory column (Bo¨tzinger and pre-
Bo¨tzinger complexes and the retrotrapezoid nucleus). For recordings
from the dorsal surface of the medulla, sensors were aligned with the
obex and placed 1.5 mm lateral to the midline so that its sensitive part
spanned from the level of obex to 1 mm rostral of obex. The identical
placement of the ATP sensors and null sensors was achieved by aligning
them to the midline, pyramidal tracts (for recordings from the ventral
surface) or obex (for recordings from the dorsal surface), landmark
blood vessels, nerve roots, and by means of the vernier scale of the ma-
nipulator. Once the sensors were placed, the exposed area of the brain-
stem and both sensors were covered with an excessive volume of modi-
fied Bulmer’s buffer (to provide glycerol for the operation of the sensor),
and a period of 20–30 min was allowed, until a steady baseline was
obtained. Note that the buffer would have been diluted by the CSF
present on the ventral surface and by the constant outflow of the CSF
from the exposed brainstem surface. However, ATP biosensor response
is insensitive to variations in glycerol concentration over the range of
0.5–5 mM.
Hypoxia was induced by ventilating the animals with a gas mixture
containing 10% O2 and 90% N2 for 5 min. To determine the precise
temporal relationship between changes in ATP concentration on the
ventral surface of the medulla and hypoxia-evoked changes in the respi-
ratory activity, in seven animals, apnea was induced by mechanically
hyperventilating the animal so that PCO2 in the arterial blood and end-
tidal level of CO2 were under the apneic threshold. In these experiments,
the hypoxic stimulus was the same (10% O2 for 5 min).
At the end of the experiment, five animals received pressure microin-
jections of pontamine sky blue dye (2% in 50 nl of 0.2 M sodium acetate)
at two locations along the rostrocaudal extent of the ventrolateral me-
dulla directly underneath the recording sites. These marked sites were
identified histologically and mapped using a stereotaxic atlas (Paxinos
and Watson, 1998). Histological analysis of the representative sensor
placements confirmed that recording sites were within the targeted re-
gions of the ventrolateral medullary surface.
In in vitro experiments, an analog of hypoxia was induced by perfusing
the chamber with aCSF in which O2 had been replaced by bubbling the
solution with 95% N2 and 5% CO2. In the majority of experiments,
changes in the PO2 of the perfusate were monitored on-line using a dis-
solved oxygen meter (model ISO2; World Precision Instruments). ATP
and null sensors were placed in equivalent positions on the slice, as
judged by the distance from the pyramidal tracts, the remaining nerve
roots, and the edge of the slice.
Effect of P2 receptor blockade in the VLM on hypoxia-induced changes in
respiratory activity. The rats (n  7) were prepared as described above
(see above, Surgical procedures). In addition, bilateral cervical vagotomy
was performed, and the animal was placed in the stereotaxic frame dorsal
side up. An occipital craniotomy was performed, and the cerebellumwas
partially removed to expose the dorsal surface of the brainstem. A three-
barrelled glassmicropipette (tip size, 20–25m)was placed in the area of
rostral VLM [stereotaxic coordinates, 2.3 mm rostral to the calamus
scriptorius, 2.0 mm lateral to midline, and 2.6–2.8 mm ventral from the
dorsal surface of the medulla oblongata (Paxinos and Watson, 1998)].
The barrels of the micropipette contained P2 receptor antagonist
pyridoxal-5-phosphate-6-azophenyl-2,4-disulphonic acid (PPADS)
(100 M, pH 7.4; Sigma, Poole, UK), vehicle [aCSF (in mM): 124 NaCl,
3.3 KCl, 2.4 CaCl2, 1.3 MgSO4, 26 NaHCO3, 1.2 KH2PO4, and 10
D-glucose], and pontamine sky blue dye (2% in 0.2 M sodium acetate).
The injectionsweremade using pressure over 5–10 s andweremonitored
using a dissecting microscope with a calibrated micrometer disk.
In the preliminary studies, we determined that the second episode of
hypoxia applied 1 h after the first episode induces an equivalent hy-
poxic ventilatory response. Therefore, we used the same experimental
animal to determine control hypoxic respiratory response after microin-
jection of aCSF into the VLM and to compare this response with that
evoked by hypoxia after administration of PPADS at the samemedullary
site. First, unilateralmicroinjection of aCSF (50 nl) wasmade into the left
VLM. Fiveminutes later, hypoxia was induced by ventilating the animals
with a gas mixture containing 10% O2 and 90% N2 for 5 min; thus,
control hypoxic ventilatory response was obtained. Subsequently, the
animal was ventilated normally for at least 1 h to reestablish physiological
levels of PO2, PCO2, and pH in the arterial blood and to resume normal
phrenic nerve activity. After this recovery period, PPADS (100M; 50 nl)
was microinjected into the same VLM site, and, after 5 min, the respira-
tory response to hypoxia was tested again. Blood gases were measured
during hypoxia episodes to ensure that arterial PO2 and PCO2 levels were
similar in both cases. The sites of microinjections were marked by pres-
sure injection of pontamine sky blue dye, identified histologically, and
mapped using a stereotaxic atlas (Paxinos and Watson, 1998).
Data analysis
Records were processed and analyzed using Spike 2 software (Cambridge
ElectronicDesign, Cambridge, UK). Changes in ATP levels are presented
as means  SEM of peak (as a micromolar concentration) and integral
(in micromolar concentration times seconds) increases in concentra-
tions. Integral increases in ATP concentrations were determined bymea-
suring area under the curve relative to a straight line joining the sensor
current level before and after the response. The integral gives a better
measure of the total production of analyte than the peak concentration.
Hypoxia-induced changes in the respiratory rate, amplitude of the
phrenic nerve bursts, and minute ventilation (respiratory rate ampli-
tude of the phrenic nerve bursts) after injection of aCSF or PPADS into
the VLM were compared using Student’s paired t test, and then the data
were normalized for graphical purposes. A value of p	 0.05 was consid-
ered significant.
Results
Release of ATP at the ventral surface of the medulla oblongata
during hypoxia
During systemic hypoxia, the ATPmicroelectrode biosensors re-
sponded with a large increase in current, which occurred 25.0
4.5 s after hypoxia-induced activation of the respiratory activity
(mean signal, 970 280 pA and 293 87 nA·s; n 19) (Figs. 2,
3). This large signal contrasted with that recorded by the “null”
sensors that lacked enzymes in the polymer coating (mean signal,
380 120 pA and 98 33 nA·s; n 18; p 0.021 and p 0.015,
respectively, vs ATP sensor) (Figs. 2, 3). We therefore concluded
that the signal recorded during hypoxia by the ATP biosensors
was attributable to the increase in ATP concentration in the area
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surrounding the sensor rather than to the generation of nonspe-
cific electroactive interferents. Sometimes, ATP and/or null sen-
sors exhibited a small negative shift around the onset of hypoxia
(Figs. 2b, 3b). This is likely to be attributable to changes in PO2 in
the neighborhood of the sensor, which consists of a Pt wire po-
larized to 500 mV and therefore exhibits some intrinsic O2 sensi-
tivity. Such shifts in sensor signal during hypoxia have been re-
ported previously in experiments in vitro and in vivo (Dale et al.,
2000; Gourine et al., 2002). We therefore do not consider this
negative shift a fall in ATP concentration
We recorded a marked increase in ATP concentration on the
ventrolateral surface of the medulla during systemic hypoxia
(Fig. 2a) that had amean amplitude of 3.0 0.7M (n 16). The
total amount of ATP released during hypoxia was estimated to be
817 214 M·s (n 16). The increase in ATP concentration on
the ventral surface of the medulla was delayed and occurred
25.0 4.5 s after hypoxia-induced augmentation of the respira-
tory activity. Experiments in animals inwhich apneawas induced
by mechanical hyperventilation confirmed that, during hypoxia,
release of ATPon the ventral surface of themedulla is delayed and
revealed that the peak of release coincides with the secondary
hypoxia-induced slowing of the respiratory rhythm (Fig. 3a,b). A
temporal relationship between changes in ATP concentration on
the ventral surface of themedulla and hypoxia-evoked changes in
the respiratory activity can be seen clearly on the expanded trace
(Fig. 3b). The amount of ATP released on the ventral surface of
the medulla during hypoxia in animals that were mechanically
hyperventilated to induce central apnea (arterial PCO2 and end-
tidal CO2 below apneic threshold) was similar ( p 0.05) to that
recorded during hypoxia in rats kept under normal ventilation.
An increase in ATP concentration on the ventrolateral surface
of themedulla was also observed during hypoxia in sinoaortically
denervated and vagotomized animals (Fig. 2b). As expected, the
hypoxic respiratory response was altered in these animals, in that
no increase in respiratory activity was observed (Fig. 2b). How-
ever, the secondary hypoxia-induced respiratory slowing was not
affected by denervation of the peripheral chemoreceptors (Fig.
2b). Again, in these experimental conditions, an increase in ATP
concentration on the ventrolateral surface of the medulla coin-
cided with the hypoxia-evoked slowing of the respiratory rhythm
(Fig. 2b). In sinoaortically denervated and vagotomized animals,
the mean amplitude of the hypoxia-induced ATP release was
4.4 3.1M (n 4), and the total amount of ATP produced was
Figure 2. Release of ATP at the ventral surface of the medulla oblongata during hypoxia in
rats. a, Representative raw data illustrating changes in the arterial blood pressure, phrenic
nerve discharge, and null and ATP sensor currents during systemic hypoxia (10% O2 in the
inspired air). b, Representative raw data illustrating changes in the arterial blood pressure,
phrenic nerve discharge, and release of ATP at the ventral surface of themedulla during hypoxia
in sinoaortically denervated and vagotomized animals. c, Release of ATPat thedorsalmedullary
surface: raw data illustrating changes in the arterial blood pressure, phrenic nerve discharge,
and release of ATP at the dorsal surface of the medulla oblongata during hypoxia in rats. IPNA,
Integrated phrenic nerve activity (arbitrary units); fR , frequency of the phrenic nerve bursts.
Arrows indicate the moment at which the concentration of ATP starts to increase above the
baseline.
Figure 3. Release of ATP at the ventral surface of the medulla oblongata during hypoxia in
rats thatweremechanically hyperventilated to induce central apnea (arterial PCO2 and end-tidal
CO2 below apneic threshold). a, Representative raw data illustrating changes in the arterial
blood pressure, phrenic nerve discharge, and null and ATP sensor currents during systemic
hypoxia (10% O2 in the inspired air). b, An expanded portion of the raw data obtained in a
different experiment, illustrating that, during hypoxia, an increase in ATP concentration on the
ventral surface of the medulla occurs after the activation of the respiratory network and peaks
during the secondary hypoxia-induced slowing of the respiratory rhythm. PNG, Phrenic neuro-
gram; IPNA, integrated phrenic nerve activity (arbitrary units). Arrows indicate the moment at
which the concentration of ATP starts to increase above the baseline.
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52.2  39.9 M·s (n  4). Therefore, the total amount of ATP
released on the ventral surface of the medulla during hypoxia in
sinoaortically denervated and vagotomized animals was signifi-
cantly smaller than that recorded during hypoxia in rats with
intact peripheral chemoreceptors (although the peak hypoxia-
induced increase in ATP concentration was similar).
Interestingly, significant hypoxia-induced release of ATP was
also recorded on the opposite surface of themedulla (Fig. 2c). An
increase in ATP concentration on the dorsomedial surface of the
medulla during systemic hypoxia had mean amplitude of 0.8 
0.4M (n 5), and the total amount of ATPproducedwas 315
182 M·s (n  5). The time course of ATP release on the dorsal
surface of themedulla was remarkably similar to that recorded on
the ventral surface (i.e., it was delayed and occurred several sec-
onds after hypoxia-induced augmentation of the respiratory ac-
tivity) (Fig. 2c).
To dissect the anatomical location of the ATP release, during
hypoxia, we performed experiments in vitro on series of horizon-
tal slices cut from the medulla oblongata (Fig. 4a). During the in
vitro analog of hypoxia (saturation of aCSF with 95%N2 and 5%
CO2), in 21 of 45 experiments, we recorded significant ATP re-
lease (mean amplitude, 1.7  0.7 M; n  21) from the most
ventral slice in the series, which contained structures located0–
400 m from the ventral surface of the medulla oblongata (Fig.
4b,c). A similar amount of ATP (mean amplitude, 1.1 0.5 M;
n 21) was released during hypoxia from the deeper structures
of the VLM located 400–800 m from the ventral surface of
the brainstem (Fig. 4b,c). Subsequent dorsal slices in the series
(800M from the ventral surface) rarely exhibited a significant
release of ATP (Fig. 4b,c). Thus, during hypoxia, ATP is released
throughout the ventral medulla in the lo-
cations corresponding approximately to
the ventral respiratory column.
P2 receptor blockade in the VLM
augments the hypoxia-induced
secondary slowing of the
respiratory rhythm
The P2 receptor antagonist PPADS was
microinjected unilaterally into the VLM,
and the effect of this treatment on the hy-
poxic respiratory response was examined
(Fig. 5).Microinjection of aCSF or PPADS
(100 M) had no effect on baseline levels
of ABP, heart rate, and phrenic nerve dis-
charge. The baseline frequency of the
phrenic nerve bursts after microinjection
of aCSF or PPADS into the VLM was
39.3 3.1 bursts/min (n 7) and 36.7
2.5 bursts/min (n 7; not significant), re-
spectively. The initial increase in fre-
quency of the phrenic nerve bursts evoked
by hypoxia was significantly reduced by
PPADS. Thus, after microinjection of
aCSF into the VLM, the hypoxia-induced
peak increase in respiratory rate was
86.7  2.5 bursts/min (n  7), whereas,
after microinjection of PPADS, it was
75.9  3.2 bursts/min (n  7; p 	 0.05).
When respiratory activitywas expressed as
minute ventilation (respiratory rate 
amplitude of the phrenic nerve bursts), a
slightly different picture emerged. The dif-
ference in the initial increase inminute ventilation failed to reach
statistical significance ( p  0.19) (Fig. 5b). However, the
hypoxia-induced secondary slowing of the respiratory rhythm
was significantly augmented by the P2 receptor blockade in the
VLM (Fig. 5). After microinjection of PPADS, the minute venti-
lation was significantly lower compared with the control 2–5min
after the onset of hypoxia (Fig. 5b).
Discussion
Our use of ATP biosensors has demonstrated in vivo and in vitro
that hypoxia induces a significant release of ATP at the ventral
surface of the medulla and within the VLM. This ATP release is
delayed; it coincides with the hypoxia-induced secondary slow-
ing of the respiratory rhythm and partially, but not entirely, de-
pends on inputs fromperipheral chemoreceptors. Blockade of P2
receptors in the VLMpotentiates the hypoxia-induced secondary
slowing of the respiratory rhythm. This finding suggests that
ATP, released in the medulla oblongata, does not act to initiate
the hypoxic decrease in ventilation but instead helps to counter-
act it and maintain respiratory activity.
Technical considerations
This is one of the first in vivo studies to use an enzyme-based
biosensor to monitor the release of ATP from the brain struc-
tures. In previous studies, we used biosensors to monitor adeno-
sine release during defense reaction and systemic hypoxia in rats
(Dale et al., 2002; Gourine et al., 2002). This study extends the
application of the purine biosensor technology and demonstrates
the feasibility of an “in vivouse” of biosensors tomeasure changes
in ATP concentrations in the brain.
Figure4. ATP is released in the ventralmedulla duringhypoxia in vitro.a, Schematic showing themedulla oblongata seen from
the ventral surface. Three horizontal slices (400m)were cut, fromwhich the first one contained the ventral surface.b, Rawdata
illustrating release of ATP from the ventralmedulla during an in vitro analog of hypoxia–perfusion of the incubation chamberwith
aCSF in which O2 had been replaced by bubbling solution with 95% N2 and 5% CO2. Note that, during hypoxia, ATP is released
predominantly by the two most ventral slices of the medulla. A simultaneous null sensor exhibited no change in current during
hypoxia (data not shown). c, Summary data showing the mean peak release of ATP from the horizontal slices of the medulla
oblongata during hypoxia. Numbers in parentheses indicate sample sizes: in 21 experiments, we were able to examine and
compare the release of ATP in the first two slices cut from the ventral surface. In nine of these experiments, we were also able to
analyze the third slice from the same series.
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When placed on the ventral surface of
themedulla, the ATP biosensors started to
respond25 s after hypoxia-induced aug-
mentation of the respiratory activity. This
delay could represent the time required
for ATP to diffuse from the site of produc-
tion and/or the response time of the ATP
biosensor. The latter is unlikely, because
the ATP biosensor responds immediately
to changes in ATP concentration and has a
10–90% response time of 10 s (Fig.
1d,e). Thus, the sensor will quickly and ac-
curately reflect the dynamic of changes in
ATP concentration in the vicinity of the
sensor. In our in vitro experiments, we ob-
served that ATP was released during hyp-
oxia predominantly throughout the first
800 m of the VLM as measured from
the ventral surface of the brainstem. This
includes significant hypoxia-induced re-
lease of ATP from the most ventral slice in
the series, suggesting that the structures
located in the close proximity to the ven-
tral surface release ATP during hypoxia. If
this is the case, then the ATP sensor was in
direct contact with the source of ATP re-
lease in our in vivo experiments, suggest-
ing that the latter is indeed delayed and
occurs several seconds after hypoxia-
induced enhancement in the respiratory
activity. Diffusion of ATP from a remote
site of release (from the sources located
400 m and more from the sensor) is
also possible, and it would give a delayed
signal at the sensor that could contribute
to the overall increase in ATP concentration during hypoxia.
Note that the ectonucleotidases in the medulla will cause rapid
breakdown of ATP and are therefore likely to limit its diffusion to
the surface. Because the sensor is insensitive to ADP or adeno-
sine, the potential breakdown products of ATP, this would di-
minish the contribution of more distant dorsal sites to the sensor
signal recorded at the ventral surface of the medulla.
Release of ATP in the ventral medulla during hypoxia in rats:
role in hypoxic ventilatory response
The recording sites in our in vivo experiments were located
400–700 m from the ventral respiratory column, which con-
tains a network of respiratory neurons (within the ventral respi-
ratory groups; Bo¨tzinger and pre-Bo¨tzinger complexes) that are
responsible for generating and shaping of the respiratory rhythm,
as well as premotor neurons responsible for transmitting this
rhythm to spinal motorneurons controlling the diaphragm and
intercostal muscles (Duffin et al., 1995; Richter and Spyer, 2001;
Feldman et al., 2003).
We and others demonstrated previously that ATP is involved
in the medullary mechanisms controlling respiratory activity.
P2X2 receptor subunits are expressed by physiologically identi-
fied respiratory neurons in the ventral respiratory column (Gou-
rine et al., 2003). ATP increases the activity of respiratory neurons
in the adult (Gourine et al., 2003) and potentiates respiratory
frequency in rhythmically active in vitro preparations from neo-
natal rats (Lorier et al., 2004). In the latter preparation, the in-
crease in respiratory activity evoked by CO2 does not seem to
involve activation of P2 receptors (Lorier et al., 2004). However,
the data obtained using an in vivo preparation of adult rat suggest
that ATP at the level of the VLM may play an important role in
central CO2 chemoreception (Spyer and Thomas, 2000; Spyer et
al., 2004). Hypercapnia-induced increases in respiration are at-
tenuated bymicroinjection of the P2 receptor antagonist suramin
into the rostral VLM (Thomas et al., 1999). In addition, suramin
and PPADS reduce the baseline firing and completely block
hypercapnia-evoked increases in the activity of VLM neurons
with inspiratory-related discharge (Thomas and Spyer, 2000).
Many respiratory neuronsmay thus be under tonic ATP-induced
excitation, which, at least in the adult, may regulate their activity
during hypercapnia.
Our new results indicate that ATP plays an important role in
themedullarymechanisms of the respiratory control during hyp-
oxia as well.We suggest that, during hypoxia, ATP released in the
VLMacts locally on respiratory neurons in the ventral respiratory
column to maintain respiratory activity in conditions when
hypoxia-induced depression of respiration occurs. During hyp-
oxia, ATP is released at the right time, in the right place, and in
sufficient quantities (3 M). Release of ATP in the VLM is
delayed, and the peak of release coincides with the period of
hypoxia-induced secondary slowing of the respiratory rhythm. In
sinoaortically denervated and vagotomized rats, in which hyp-
oxia induces only the depression of respiration, ATP release is still
present and yet again coincides with the latter phase of respira-
tory depression. In vitro studies presented in Figure 4 indicate
that, during hypoxia, ATP is released in the locations correspond-
Figure 5. P2 receptor blockade in the ventrolateral medulla augments hypoxia-induced secondary slowing of the respiratory
rhythm in rats. a, Representative raw data obtained sequentially in the same experiment, illustrating the effect of P2 receptor
antagonist PPADS (100M, 50 nl)microinjected unilaterally into the ventrolateralmedulla on the respiratory response evoked by
systemic hypoxia (10%O2 in the inspired air). Note thedeepeningof thehypoxia-induced secondary respiratory response: slowing
of the respiratory rhythm by the P2 receptor blockade in the ventral medulla. b, Summary data showing the effect of PPADS on
changes in minute ventilation evoked by hypoxia. IPNA, Integrated phrenic nerve activity (arbitrary units); fR , frequency of the
phrenic nerve bursts. Numbers in parentheses indicate sample sizes. Significant difference, *p	 0.05.
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ing approximately to the ventral respiratory column. Finally, P2
receptor blockade in the VLM potentiates the hypoxia-induced
secondary slowing of the respiratory rhythm.
It is important to note that P2 receptor antagonist PPADSwas
microinjected unilaterally into the rostral part of the VLM. We
cannot readily estimate the rate and distance of PPADS diffusion
from the injection site; however, it is very unlikely that P2 recep-
tors in the whole ventral respiratory column have been affected.
Multiplemicroinjections of PPADS along the rostrocaudal extent
of the VLM or bilateral microinjections may have produced a
greater effect on the hypoxic respiratory response; however, we
were concerned that multiple injections might have compro-
mised the neuronal function in this important area of the me-
dulla and confounded the result of the experiment. Therefore,
PPADSwas injected unilaterally into the VLM. Nevertheless, this
treatment still resulted in a significant augmentation of the
hypoxia-induced secondary slowing of the respiratory rhythm.
These results are supported by our studies on conscious P2X2-
deficient mice using whole-body plethysmography (Rong et al.,
2003). During hypoxia (7.5% O2 in the breathing air), profound
respiratory depression was observed in P2X2-deficient mice but
not in their wild-type counterparts (Rong et al., 2003). These
results complement the data presented here and suggest that ATP
acting via P2X2 receptors helps to counteract hypoxia-induced
respiratory depression.
There is another aspect of the study conducted in our labora-
tory using P2X2-deficient mice that is related to the conclusions
of the present investigation.We demonstrated that, in the carotid
body (primary peripheral chemosensory site), ATP is acting dur-
ing hypoxia as the main transmitter to stimulate afferent termi-
nals of the carotid sinus nerve, which convey information about
arterial PO2 levels to the brainstem respiratory centers (Rong et
al., 2003). Therefore, the actions of ATP at the two sites are syn-
ergistic: ATP in the carotid body initiates the response to hypoxia
(increases ventilation), and the later release of ATP in the ventral
respiratory column acts to maintain this initial response in the
face of the secondary hypoxia-induced depression of respiration.
It seems that ATP release during hypoxia is not restricted to
the VLM. We also observed a significant hypoxia-induced in-
crease in ATP concentration on the dorsal surface of themedulla.
Interestingly, the time course of changes in ATP concentration
on the dorsal surface in relation to changes in respiration was
similar to that recorded on the ventral surface. These data are in
accord with our previous observation that ecto-5-nucleotidase in-
hibitor ,-methylene ADP greatly reduces the hypoxia-evoked re-
lease of adenosine at the dorsal surface, indicating the previous re-
lease ofATP (Gourine et al., 2002). Basedon thesedata,we conclude
that, at least in themedulla, the release of ATPduring hypoxia could
be widespread, and different medullary structures are capable of
releasing ATP during hypoxic conditions.
However, the origins and mechanisms of ATP release in the
medulla during hypoxia remain unknown. Both neural and non-
neural sources may contribute to the increase in extracellular
concentration of ATP in hypoxic conditions. It remains to be
determined whether ATP is released as a cotransmitter via con-
ventionalmechanisms and/or by other routes, such as hemichan-
nels in glia.
In any case, ATP released in the VLM during hypoxia will
eventually be broken down in the extracellular space to adeno-
sine. Several lines of evidence implicate adenosine as a mediator
for hypoxia-induced depression of respiration. Hypoxic respira-
tory depression is reduced by the administration of adenosine
receptor antagonists (Runold et al., 1989; Thomas and Marshall,
1994; Schmidt et al., 1995; Chau and Koos, 1999) or in mice
lacking adenosine A1 receptor (Johansson et al., 2001). During
hypoxia, adenosine levels rise in theVLM in the cat (Richter et al.,
1999). Indeed, with adenosine biosensors, we demonstrated de-
layed hypoxia-induced release of adenosine in the ventral and
dorsal medullary regions of the rat (Gourine et al., 2002). The
results of the present study show a new functional role for the
ATP-mediated purinergic signaling in the medullary mecha-
nisms controlling respiratory activity and suggest that, during
sustained hypoxia, the central respiratory drive may partially de-
pend on the balance between, respectively, the excitatory and
inhibitory actions of ATP and adenosine in the ventral respira-
tory column.
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